THERAPEAK X-VIVO
Live / Registered — Registered (as of 19 May 2026)
What this means for you
Registered since 19 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 May 2032: the §8 declaration of use).
Record
- Serial number
- 99310808
- Registration number
- 8259538
- Mark type
- Word mark
- Filed
- 30 Jul 2025
- Published for opposition
- 31 Mar 2026
- Registered
- 19 May 2026
- Next maintenance filing
- §8 declaration of use, due by 19 May 2032 (grace period to 19 Nov 2032)
- Attorney of record
- Lawrence J. Crain
Goods and services
- Class 001 — Chemicals: Cell growth media for growing cells for use in scientific research
- Class 005 — Pharmaceuticals: Cell growth media for growing cells for medical or clinical use
Owner
- Lonza Walkersville, Inc., Walkersville, MD, US
- Lonza Walkersville, Inc., Walkersville, MD, US
- Lonza Walkersville, Inc., Walkersville, MD, US
Prior registrations
Prosecution history
- 19 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Dec 2025 — NON-FINAL ACTION E-MAILED
- 12 Dec 2025 — NON-FINAL ACTION WRITTEN
- 10 Dec 2025 — ASSIGNED TO EXAMINER
- 08 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED